Archives

by in
Entry Author Date Location
Forma Gets $225M More, And a Potential Buyout, From Celgene 04/01/14 Boston
Q&A: Behind Ignyta’s New Strategy on Cancer Drugs and Diagnostics 12/09/13 San Diego
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
Atlas Startup, Rodin, Hopes to Rewire Neurons to Improve Memory 08/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Translating Nobel Science Into Novel Drugs 10/12/12 San Francisco
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Epizyme Gets $90M in Epigenetics Partnership with Celgene 04/26/12 Boston
UCSD Spinoff NexDx Aims to Diagnose Rheumatoid Arthritis 04/11/12 San Diego
Genentech Pours $95M Into Constellation’s Drug Platform 01/17/12 Boston
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News 09/16/11 Boston
Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A 09/12/11 Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial 09/06/11 Boston
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Constellation Pharma Raises $15M for Epigenetic Drugs 06/06/11 Boston
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai 03/10/11 Boston
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients 12/10/10 Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News 06/04/10 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO 03/24/10 Boston
New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research 09/01/09 Boston
Constellation Pharma Hires New CEO, Collects Last $17M of its Series A Financing 08/13/09 Boston
Page 1 of 2 next page »